FDA Import Refusal SCS-2543164-5/11/5 — Rubicon Research Canada Limited
The FDA refused shipment SCS-2543164-5/11/5 from Rubicon Research Canada Limited (Canada) on Jan 30, 2019. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 75
Refusal details
- Date
- Jan 30, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62YCA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 75